Sameer Joshi

Assistant Professor Department of Pharmaceutical Sciences, College of Pharmacy
B. Pharm, MS, MRes, PhD
Office: Room 2510
Phone: (305) 760-7497
Email: SJoshi@ULarkin.org
Hours: By Appointment

Research Interest
Dr. Joshi is particularly interested in designing and developing novel drug delivery systems (NDDS), including liposomes, niosomes, polymer nanoparticles, and biomaterial-based hydrogels. To study (production and analysis) these NDDS, Dr. Joshi considers the usage of modern technologies, including but not limited to microfluidics, 3D printing, chromatography, spectroscopy, and microscopy. Dr. Joshi is always open to collaborations intended for improvements in drug delivery science.

Qualifications
Ph.D. Pharmaceutics/Drug Delivery, Aston University (UK), 2017
M. Res. Pharmaceutical Analysis, Nottingham Trent University (UK), 2013
M. S. Analytical Bioscience, University of Huddersfield (UK), 2010
B. Pharmacy, Rajiv Gandhi University of Health Sciences (India), 2008

Employment
Postdoctoral Research Associate, Alabama State University (USA), 2017-2022
Lab Demonstrator (Pharmaceutics), Aston University (UK), 2014-2017
Research Fellow (Analytical R&D, Oncology), Emcure Pharmaceuticals Inc. (India), 2011-2012
Placement Researcher, University of Huddersfield (UK), 2010-2011

Teaching Interests
Dr. Joshi’s teaching interests include pharmaceutics, pharmaceutical calculations, and biopharmaceutics.

Research Interest

Dr. Joshi is particularly interested in designing and developing novel drug delivery systems (NDDS), including liposomes, niosomes, polymer nanoparticles, and biomaterial-based hydrogels. To study (production and analysis) these NDDS, Dr. Joshi considers the usage of modern technologies, including but not limited to microfluidics, 3D printing, chromatography, spectroscopy, and microscopy. Dr. Joshi is always open to collaborations intended for improvements in drug delivery science.

Research Profile

Dr. Joshi’s research involves the formulation and development of age-appropriate pediatric and geriatric populations. The use of novel drug delivery systems (NDDS) such as liposomes, niosomes, polymeric nanoparticles, and biomaterial-based hydrogels can enhance the acceptability of the formulations by providing extended stability, taste masking, and easy administration. The research also involves extemporaneous formulation development that helps prepare medicines by compounding ingredients when no commercial forms are available due to age factors. Dr. Joshi’s research also explores the use of NDDS in the prophylaxis and treatment of viral and bacterial infections. Dr. Joshi’s recent publications highlight his research.

Publications

Joshi Sameer, Rajnish Sahu, Vida Dennis, and Shree R. Singh. “Nanofiller-Enhanced Soft Non-Gelatin Alginate Capsules for Modified Drug Delivery.” Pharmaceuticals 14.4 (2021): 355.

Joshi Sameer, Roderica White, Rajnish Sahu, Vida Dennis, and Shree R. Singh. “Comprehensive Screening of Drug Encapsulation and Co-Encapsulation into Niosomes Produced Using a Microfluidic Device.” Processes 8.5 (2020): 535.

Joshi Sameer, Swapnil Bawage, Pooja Tiwari, Daniel Kirby, Yvonne Perrie, Vida Dennis, and Shree R. Singh. “Liposomes: a promising carrier for respiratory syncytial virus therapeutics.” Expert opinion on drug delivery (2019): 1-12.

Crenshaw Brennetta J., Sanjay Kumar, Courtnee’R. Bell, Leandra B. Jones, Sparkle D. Williams, Sabita N. Saldanha, Sameer Joshi, Rajnish Sahu, Brian Sims, and Qiana L. Matthews. “Alcohol Modulates the Biogenesis and Composition of Microglia-Derived Exosomes.” Biology 8, no. 2 (2019): 25.

Chaudhari Atul A., Sameer Joshi, Komal Vig, Rajnish Sahu, Saurabh Dixit, Rade Baganizi, Vida A. Dennis, Shree R. Singh, and Shreekumar Pillai. “A three-dimensional human skin model to evaluate the inhibition of Staphylococcus aureus by antimicrobial peptide-functionalized silver carbon nanotubes.” Journal of biomaterials applications 33, no. 7 (2019): 924-934.

Joshi Sameer, Atul Chaudhari, Vida Dennis, Daniel Kirby, Yvonne Perrie, Shree Singh. “Anti-RSV peptide-loaded liposomes for the inhibition of respiratory syncytial virus.” Bioengineering 5, no. 2 (2018): 37.

Joshi Sameer, Vig Komal, Singh Shree R., Advanced Hydrogels for Biomedical Applications. Biomedical Journal of Scientific & Technological Research, (2018), 5(1), 1-5.

VK C Ortiz J.D., Joshi Sameer, Vig Komal, Singh Shree R., Impact of Docetaxel Conjugated Nanodiamonds on gene expression of prostate cancer (PC3) cells. TechConnect Briefs, Biomaterials and Biomedical, (2018), 5(1), 65-68.

Joshi Sameer, Vig Komal, Dennis Vida, Singh Shree R., Hydrogel–based scaffolds for tissue engineering. TechConnect Briefs, Biomaterials and Biomedical, (2018), 5(1), 20-23.

Joshi Sameer, Kirby Daniel, Perrie Yvonne, Singh Shree R, Novel nano-biomaterials for inhibition of respiratory syncytial virus. TechConnect World Innovation Conference and Expo, Technical Proceedings (2017), Volume 3, p. 75-78.

Joshi Sameer, Liposomes: a multifaceted delivery system, Thesis (Ph.D.), EThoS ID-UK.bl.ethos.74260, Aston University, (2017).

Joshi Sameer, Maryam T. Hussain, Carla B. Roces, Giulia Anderluzzi, Elisabeth Kastner, Stefano Salmaso, Daniel J. Kirby, and Yvonne Perrie. “Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.” International journal of pharmaceutics 514, no. 1 (2016): 160-168.

Publication List Via Google Scholar:

https://scholar.google.com/citations?user=s6GH068AAAAJ&hl=en

Publication List Via PubMed (nih.gov):

https://www.ncbi.nlm.nih.gov/myncbi/sameer.joshi.1/bibliography/public/

Awards and Honors

  • Trainee Award-TMD Group (2020), Controlled Release Society (CRS).
  • International Travel Award (2016), UK-Ireland Controlled Release Society (UKICRS).
  • Overseas Research Travel Award (2016), Aston University, Birmingham, UK.
  • Overseas Research Scholarship (2014), Aston University, Birmingham, UK.
  • International Science Scholarship (2012), Nottingham Trent University, Nottingham, UK.